e-learning
resources
Barcelona 2013
Sunday, 08.09.2013
Disease control and quality of life in airway diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Asthma control is reached in a large majority of asthmatics treated with omalizumab. An Italian observational study
F. Novelli, G. Lenzini, M. Latorre, L. Malagrinò, F. L. Dente, P. L. Paggiaro (Pisa, Italy)
Source:
Annual Congress 2013 –Disease control and quality of life in airway diseases
Session:
Disease control and quality of life in airway diseases
Session type:
Thematic Poster Session
Number:
811
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
F. Novelli, G. Lenzini, M. Latorre, L. Malagrinò, F. L. Dente, P. L. Paggiaro (Pisa, Italy). Asthma control is reached in a large majority of asthmatics treated with omalizumab. An Italian observational study. Eur Respir J 2013; 42: Suppl. 57, 811
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Related content which might interest you:
Effectiveness of omalizumab in Greek patients with severe allergic asthma (SAA): The SMILE study
Source: International Congress 2016 – Asthma points to ponder
Year: 2016
Interim analysis of a prospective study investigating oral corticosteroid (OCS) use in omalizumab treated severe allergic asthma patients: APEX II study
Source: International Congress 2014 – Intervening in allergic asthma
Year: 2014
Tiotropium for uncontrolled asthma (a meta-analysis)
Source: Annual Congress 2013 –Treatment of asthma
Year: 2013
Ketamine versus aminophylline for status asthmatic in children: A randomized, controlled trial
Source: International Congress 2014 – Lung disease in neonates and beyond
Year: 2014
P-PiXel: A ’real-life’ evaluation of omalizumab use in asthmatic patients
Source: International Congress 2016 – Asthma management
Year: 2016
APEXII- A prospective study investigating the efficacy of omalizumab treatment in severe allergic asthma
Source: International Congress 2015 – Immune aspects of asthma and other airway diseases
Year: 2015
The elderly subjects with asthma (ELSA) study. Asthma in subjects ≥65 yrs and its overlap with COPD
Source: Annual Congress 2013 –Is it really asthma?
Year: 2013
Asthma clusters in a real asthmatic population, treated in secondary medical care
Source: International Congress 2014 – Asthma: clinical problems
Year: 2014
FeNO in children with asthma is related to inhaled corticosteroids adherence, not to asthma control
Source: International Congress 2014 – Paediatric asthma: markers and molecules
Year: 2014
A pilot study for markers which can reflect asthmatic activity before and after reduction of inhaled corticosteroids
Source: Annual Congress 2013 –Assessment of airway inflammation by exhaled gases
Year: 2013
First clinical trial of a new IgE-adsorber in allergic asthma
Source: International Congress 2015 – Novel mechanisms and treatments in allergy and asthma
Year: 2015
Clinical profile and treatment of elderly patients hospitalized for acute exacerbation of asthma . A comparative study
Source: International Congress 2014 – Asthma: clinical problems
Year: 2014
A population-based study of animal component sensitization, asthma and rhinitis in school children
Source: International Congress 2015 – Prevalence of respiratory disease
Year: 2015
Five-year clinical study of children with atopic asthma
Source: International Congress 2014 – Paediatric asthma: epidemiology and risk factors
Year: 2014
Work related symptoms of adult patients with asthma: A multicenter, national, questionnaire based study
Source: International Congress 2015 – Work, environment and the epidemiology of asthma
Year: 2015
Risk factors for poor asthma control in asthmatic children
Source: International Congress 2014 – Paediatric asthma: pharmacological and non-pharmacological management
Year: 2014
Long-term using of omalizumab in children with atopic severe persistent non-controlled asthma
Source: Annual Congress 2013 –Uncontrolled and severe asthma in children
Year: 2013
Introduction of new asthma guidelines did not improve asthma control in a Dutch paediatric population
Source: International Congress 2014 – Paediatric asthma: pharmacological and non-pharmacological management
Year: 2014
Global evaluation of treatment effectiveness (GETE) is an accurate predictor of response to omalizumab in patients with severe allergic asthma: A pooled analysis
Source: International Congress 2014 – Intervening in allergic asthma
Year: 2014
The control of asthma in real life: Baseline evaluation of a long-term study
Source: International Congress 2016 – Monitoring airway diseases with clinical tools
Year: 2016
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept